Abstract
<jats:p>Background: Biochemical recurrence (BCR) occurs in up to 40% of men following radical prostatectomy (RP). Current risk models rely primarily on clinicopathologic variables and may not fully capture the biological heterogeneity associated with recurrence. The Decipher Genomic Classifier (DGC), prostate-specific membrane antigen positron emission tomography (PSMA-PET), and multiparametric magnetic resonance imaging (mpMRI) provide complementary prognostic information that may improve prediction. Objective: To develop and evaluate machine learning (ML) models integrating DGC, PSMA-PET, and mpMRI for preoperative prediction of BCR following RP. Methods: This retrospective study included patients with available preoperative DGC, PSMA-PET, mpMRI, and clinicopathologic data. Logistic regression (LR), random forest (RF), and XGBoost models were developed using single- and multimodality feature combinations. Early- and intermediate-fusion strategies were evaluated. Performance was assessed using an area under the receiver operating characteristic curve (AUC) and accuracy. Clinical utility was evaluated using decision curve analysis. Results: XGBoost consistently outperformed LR and RF. DGC achieved the highest single-modality performance (AUC 0.94, accuracy 86.7%). Among multimodal models, DGC combined with PSMA-PET using intermediate fusion achieved the best overall performance (AUC 0.93, accuracy 87.0%). Addition of mpMRI reduced performance (AUC 0.85, accuracy 83.0%). Decision curve analysis demonstrated positive net benefit across clinically relevant thresholds. Conclusion: XGBoost-based multimodal fusion improved preoperative BCR prediction following RP. DGC was the strongest individual predictor, while integration with PSMA-PET provided the best overall performance, supporting the potential of radiogenomic ML models for personalized risk stratification.</jats:p>